Personally, I thought yesterday's conference call was the best one since I've been invested in CYDY (Dec 2019) as it relates to COVID. The market's reaction is despicable, but we know there are many forces that do not want CytoDyn to succeed. They are scared. In the long run these obstacles will make CytoDyn stronger as a company, even if we don't win the COVID approvals. COVID will be over with before you know it. The real prize, I should say the gift to world, is Leronlimab's Cancer and NASH solution. People on this board, thank you for your contributions and the knowledge you have shared with all of us. We will persevere!